Paul Tudor Jones's LUNG Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 11,028 shares of Pulmonx Corporation (LUNG) worth $14,226, representing 0.00% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in LUNG, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 67,123 shares. Largest reduction occurred in Q4 2025, reducing 188,209 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Pulmonx Corporation (LUNG) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pulmonx Corporation (LUNG) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -11,884 | Reduce 51.87% | 11,028 | $1.29 |
| Q4 2025 | -188,209 | Reduce 89.15% | 22,912 | $2.21 |
| Q3 2025 | -29,930 | Reduce 12.42% | 211,121 | $1.62 |
| Q2 2025 | +36,233 | Add 17.69% | 241,051 | $2.59 |
| Q1 2025 | +55,716 | Add 37.37% | 204,818 | $6.73 |
| Q4 2024 | +12,282 | Add 8.98% | 149,102 | $6.79 |
| Q3 2024 | +1,135 | Add 0.84% | 136,820 | $8.29 |
| Q2 2024 | +16,215 | Add 13.57% | 135,685 | $6.34 |
| Q1 2024 | +67,123 | Add 128.23% | 119,470 | $9.27 |
| Q4 2023 | +52,347 | New Buy | 52,347 | $12.75 |
| Q3 2023 | -29,885 | Sold Out | 0 | $0.00 |
| Q2 2023 | +13,787 | Add 85.64% | 29,885 | $13.11 |
| Q1 2023 | +16,098 | New Buy | 16,098 | $0.01 |
| Q3 2022 | -22,064 | Sold Out | 0 | $0.00 |
| Q2 2022 | +22,064 | New Buy | 22,064 | $14.73 |
| Q1 2022 | -6,255 | Sold Out | 0 | $0.00 |
| Q4 2021 | -10,332 | Reduce 62.29% | 6,255 | $32.13 |
| Q3 2021 | -22,067 | Reduce 57.09% | 16,587 | $35.99 |
| Q2 2021 | +25,721 | Add 198.88% | 38,654 | $44.11 |
| Q1 2021 | +12,933 | New Buy | 12,933 | $45.77 |
Paul Tudor Jones's Pulmonx Corporation Investment FAQs
Paul Tudor Jones first purchased Pulmonx Corporation (LUNG) in Q1 2021, acquiring 12,933 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Pulmonx Corporation (LUNG) for 20 quarters since Q1 2021.
Paul Tudor Jones's largest addition to Pulmonx Corporation (LUNG) was in Q1 2024, adding 119,470 shares worth $1.11 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 11,028 shares of Pulmonx Corporation (LUNG), valued at approximately $14,226.
As of the Q1 2026 filing, Pulmonx Corporation (LUNG) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Pulmonx Corporation (LUNG) was 241,051 shares, as reported at the end of Q2 2025.